BTI Biotechnology Institute
Ronald M. Sanchez-Avila, MD, PhD, MBA, MSc, is a highly accomplished ophthalmologist and researcher currently serving as the Director of Research and Development at Miranza in Madrid and as an ophthalmologist specializing in ocular surface and retina at Miranza IOA. With extensive experience spanning various prominent healthcare institutions, Ronald has held key roles including Medical Advisor at BTI Biotechnology Institute and ophthalmologist positions at Quirónsalud and OFTALVIST. Educationally, Ronald possesses a diverse academic background, including a PhD in Health Sciences focused on Ophthalmology and Translational Medicine from Universidad de Oviedo, alongside multiple fellowships and master's degrees in related fields. Ronald’s expertise encompasses ophthalmic care, health economics, pharmacovigilance, and medical training.
This person is not in any teams
This person is not in any offices
BTI Biotechnology Institute
BTI Biotechnology Institute is a Spanish multinational company specialising in biomedicine and biotechnology whose activity focuses on two areas: regenerative medicine and oral implantology. It was founded in 1999 by Dr. Eduardo Anitua, the company’s president and scientific director.